DNA GTx’s KRAS Test detects 18 variants located in exons 2, 3, and 4 of the KRAS gene. This focused mutation analysis helps oncologists tailor treatment strategies for patients with colorectal and lung cancer by identifying clinically relevant variants that impact therapy response and prognosis.
Yes. A doctor must order the test to ensure the results are used appropriately to guide treatment.
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.